×
About 207 results

ALLMedicine Schnitzler Syndrome Center

Research & Reviews  103 results

Images of the month 1: Schnitzler syndrome: an acquired autoinflammatory syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081793
Clinical Medicine (London, England); Zampeli E, Marinos L et. al.

Mar 19th, 2020 - Images of the month 1: Schnitzler syndrome: an acquired autoinflammatory syndrome.|2020|Zampeli E,Marinos L,Karakatsanis SJ,|

Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.
https://doi.org/10.1016/j.jaci.2019.12.909
The Journal of Allergy and Clinical Immunology; Krause K, Bonnekoh H et. al.

Jan 15th, 2020 - Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.|2020|Krause K,Bonnekoh H,Ellrich A,Tsianakas A,Wagner N,|

Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome.
https://doi.org/10.1080/08916934.2019.1680649
Autoimmunity Alix L, Néel A et. al.

Oct 27th, 2019 - Introduction: Schnitzler syndrome is an auto-inflammatory disease defined by chronic urticarial eruption and monoclonal gammopathy. 18F fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is often performed, but its utilit...

Neutrophilic urticarial dermatosis: an entity bridging monogenic and polygenic autoinfl...
https://doi.org/10.1111/jdv.15984
Journal of the European Academy of Dermatology and Venereology : JEADV References; Gusdorf L, Lipsker D

Sep 28th, 2019 - Neutrophilic urticarial dermatosis (NUD) has been described in 2009. Clinically, it is an eruption of rose or red macules or slightly elevated plaques, vanishing within 24 h. It occurs mostly on the trunk and the limbs. Extracutaneous signs such a...

Ilaris (Canakinumab) in the Schnitzler Syndrome
https://clinicaltrials.gov/ct2/show/NCT01245127

Jul 4th, 2019 - Description of the study: Objectives: Primary objective: To evaluate if canakinumab 150mg every 8 weeks can induce and maintain clinical remission in patients with the Schnitzler syndrome. Secondary objectives: To test if canakinumab 150mg can ind...

see more →

Clinicaltrials.gov  103 results

Images of the month 1: Schnitzler syndrome: an acquired autoinflammatory syndrome.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081793
Clinical Medicine (London, England); Zampeli E, Marinos L et. al.

Mar 19th, 2020 - Images of the month 1: Schnitzler syndrome: an acquired autoinflammatory syndrome.|2020|Zampeli E,Marinos L,Karakatsanis SJ,|

Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.
https://doi.org/10.1016/j.jaci.2019.12.909
The Journal of Allergy and Clinical Immunology; Krause K, Bonnekoh H et. al.

Jan 15th, 2020 - Long-term efficacy of canakinumab in the treatment of Schnitzler syndrome.|2020|Krause K,Bonnekoh H,Ellrich A,Tsianakas A,Wagner N,|

Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome.
https://doi.org/10.1080/08916934.2019.1680649
Autoimmunity Alix L, Néel A et. al.

Oct 27th, 2019 - Introduction: Schnitzler syndrome is an auto-inflammatory disease defined by chronic urticarial eruption and monoclonal gammopathy. 18F fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is often performed, but its utilit...

Neutrophilic urticarial dermatosis: an entity bridging monogenic and polygenic autoinfl...
https://doi.org/10.1111/jdv.15984
Journal of the European Academy of Dermatology and Venereology : JEADV References; Gusdorf L, Lipsker D

Sep 28th, 2019 - Neutrophilic urticarial dermatosis (NUD) has been described in 2009. Clinically, it is an eruption of rose or red macules or slightly elevated plaques, vanishing within 24 h. It occurs mostly on the trunk and the limbs. Extracutaneous signs such a...

Ilaris (Canakinumab) in the Schnitzler Syndrome
https://clinicaltrials.gov/ct2/show/NCT01245127

Jul 4th, 2019 - Description of the study: Objectives: Primary objective: To evaluate if canakinumab 150mg every 8 weeks can induce and maintain clinical remission in patients with the Schnitzler syndrome. Secondary objectives: To test if canakinumab 150mg can ind...

see more →

News  1 results

Successful Treatment of Schnitzler Syndrome With Canakinumab
https://www.mdedge.com/dermatology/article/86939/urticaria/successful-treatment-schnitzler-syndrome-canakinumab
Robbie Pesek, MD, Roger Fox, MD

Sep 3rd, 2014 - To the Editor: Schnitzler syndrome occurs with a triad of chronic urticaria, recurring fevers, and monoclonal gammopathy. It was recognized as a clinical entity in 1972; now nearly 200 patients are reported in the medical literature.

see more →